The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(3-fluoro-4-(7-(2-(2-(2-methoxyethoxy)ethoxy)phenyl)thieno[2,3-d]pyridazin-4-ylamino)phenyl)acetamide ID: ALA4570366
PubChem CID: 155562849
Max Phase: Preclinical
Molecular Formula: C25H25FN4O4S
Molecular Weight: 496.56
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COCCOCCOc1ccccc1-c1nnc(Nc2ccc(CC(N)=O)cc2F)c2ccsc12
Standard InChI: InChI=1S/C25H25FN4O4S/c1-32-9-10-33-11-12-34-21-5-3-2-4-17(21)23-24-18(8-13-35-24)25(30-29-23)28-20-7-6-16(14-19(20)26)15-22(27)31/h2-8,13-14H,9-12,15H2,1H3,(H2,27,31)(H,28,30)
Standard InChI Key: VFWQGMJXTDLSNC-UHFFFAOYSA-N
Molfile:
RDKit 2D
35 38 0 0 0 0 0 0 0 0999 V2000
41.8047 -19.4888 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9814 -17.0399 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6911 -16.6304 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.6882 -15.8078 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.9796 -15.4025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2734 -16.6309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2746 -15.8144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.4984 -15.5609 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
37.0174 -16.2208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.4964 -16.8820 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9744 -14.5906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6819 -14.1793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6785 -13.3629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9684 -12.9568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2602 -13.3730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2671 -14.1881 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9812 -17.8571 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.6888 -18.2658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6845 -19.0812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3913 -19.4899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.1000 -19.0815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0976 -18.2600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3903 -17.8550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.5155 -19.0799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.2236 -19.4878 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.5146 -18.2627 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.9756 -19.4877 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
40.3911 -14.5854 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
41.0973 -14.1743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.8065 -14.5803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.5127 -14.1692 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
43.2219 -14.5753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.9281 -14.1642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.6373 -14.5702 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
45.3435 -14.1591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 7 1 0
6 7 2 0
7 8 1 0
8 9 1 0
9 10 2 0
10 6 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
5 11 1 0
2 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
21 1 1 0
1 24 1 0
24 25 1 0
24 26 2 0
19 27 1 0
12 28 1 0
28 29 1 0
29 30 1 0
30 31 1 0
31 32 1 0
32 33 1 0
33 34 1 0
34 35 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 496.56Molecular Weight (Monoisotopic): 496.1581AlogP: 4.31#Rotatable Bonds: 12Polar Surface Area: 108.59Molecular Species: NEUTRALHBA: 8HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.93CX Basic pKa: 0.83CX LogP: 3.44CX LogD: 3.44Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.28Np Likeness Score: -1.65
References 1. Tsuji T, Yamaguchi M, Kuroyanagi J, Furuzono S, Konishi M, Terayama K, Tanaka J, Saito M, Kobayashi Y.. (2019) Discovery of novel pyridazine derivatives as glucose transporter type 4 (GLUT4) translocation activators., 29 (14): [PMID:31101471 ] [10.1016/j.bmcl.2019.05.013 ]